Article
NUTLEY, N.J. - An FDA-approved program is offering a "smart" way to prevent pregnancies during isotretinoin (Accutane) use.
Patients with Vitiligo Have a Lower Risk of Developing Serious Infections, New Poster Finds
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
The Role of Medication in Effective Weight Loss
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
PASI and QoL: A New Approach to Treatment Goals
Top 5 Articles of the Week: March 23-28